Denys, Damiaan <br/><br/>
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.  [electronic resource] 

 -  The Journal of clinical psychiatry  Aug 2004 
 - 1040-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-6689 
<br/><br/><label>Standard No.: </label>10.4088/jcp.v65n0803  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Ambulatory Care<br/>Antipsychotic Agents--adverse effects<br/>Diagnostic and Statistical Manual of Mental Disorders<br/>Dibenzothiazepines--adverse effects<br/>Dizziness--chemically induced<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Obsessive-Compulsive Disorder--drug therapy<br/>Placebos<br/>Psychiatric Status Rating Scales<br/>Quetiapine Fumarate<br/>Selective Serotonin Reuptake Inhibitors--therapeutic use<br/>Sleep--drug effects<br/>Treatment Outcome<br/>Xerostomia--chemically induced